Pregled bibliografske jedinice broj: 717818
Potential benefitial role of sevelamer hydrochloride in diabetic retinopathy
Potential benefitial role of sevelamer hydrochloride in diabetic retinopathy // Medical hypotheses, 80 (2013), 4; 431-435 doi:10.1016/j.mehy.2012.12.035 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 717818 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Potential benefitial role of sevelamer hydrochloride in diabetic retinopathy
Autori
Drača, Nataša ; Lazić, Ratimir ; Simić, Petra ; Dumić-Čule, Ivo ; Luetić Tikvica, Ana ; Gabrić, Nikica ;
Izvornik
Medical hypotheses (0306-9877) 80
(2013), 4;
431-435
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
sevelamer hydrochloride; diabetic retinopathy
Sažetak
Patients with chronic kidney disease (CKD) experience co-morbid illnesses, including cardiovascular disease and retinopathy. Sevelamer hydrochloride (Renagel) ; a non-calcium phosphate binder reduces coronary artery and aortic calcification as compared to clacium containing phosphate binders and additionally effects inflammatory biomarkers such as C-reactive protein (CRP), and lowers LDL cholesterol in patients with CKD. Since retinopathy is proven to be associated with increased coronary calcification, shared pathophysiological processes may contribute to both microvascular and macrovascular disease. We here suggest three different mechanisms of possible sevelamer influence on the retinopathy: (1) by direct effect on the microvasculature through lowering CRP and LDL, involved in endothelial dysfunction and atherogenesis, (2) indirectly by attenuation of vascular calcification of aorta and carotid internal artery, it reduces ischaemia and improves circulation in the opthalmic artery and hence postponing retinopathy, (3) through hypertension by reducing atherosclerosis and calcification of carotid arteries, sevelamer decreases stiffness and intima-media wall thickness, therefore lowering blood pressure, which is well known to increase progression of diabetic retinopathy. So far no studies have yet been published on the direct influence of sevelamer on the retinopathy which we believe has good theoretical background. With its combined macrovascular and microvascular effect, sevelamer could potentially postpone and/or decrease retinopathy in diabetic patients with hypertension, and that are on hemodialysis or even predialysis patients.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Rijeka,
Medicinski fakultet, Zagreb,
Klinička bolnica "Sveti Duh",
Specijalna bolnica Svjetlost
Profili:
Petra Šimić
(autor)
Ratimir Lazić
(autor)
Nikica Gabrić
(autor)
Nataša Drača
(autor)
Ivo Dumić-Čule
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE